Recherche
-
Enriching single-arm clinical trials with external controls: possibilities and pitfalls
(Blood Advances. pp. bloodadvances.2022009167, 2022-12-19)Article de revueLibre accès -
The respiratory microbiota alpha-diversity in chronic lung diseases: a systematic review and meta-analysis
(32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), pt, Lisbonne, 2022)Autre communication scientifique (congrès sans actes - poster - séminaire...) -
Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?
(Anaesthesia Critical Care & Pain Medicine. vol. 41, n° 2, pp. 101055, 2022-04)Article de revue -
Doubly robust evaluation of high-dimensional surrogate markers
(Biostatistics, 2022-07-06)Article de revue -
High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines
(Science Advances. vol. 8, n° 45, 2022-11-11)Article de revue -
Methodological guidelines to estimate population-based health indicators using linked data and/or machine learning techniques
(Archives of Public Health. vol. 80, n° 1, pp. 9, 2022-01-04)Article de revueLibre accès -
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
(eLife. vol. 11, pp. e75427, 2022-07-08)Article de revueLibre accès -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
(PLoS Medicine. vol. 19, n° 1, 2022-01-11)Article de revueLibre accès -
Global Variations in Event-Based Surveillance for Disease Outbreak Detection: Time Series Analysis
(JMIR Public Health and Surveillance. vol. 8, n° 10, 2022-10-31)Article de revueLibre accès -
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
(EBioMedicine. vol. 80, 2022-06)Article de revueLibre accès